SciClone Pharmaceuticals (Holdings) Limited

Industry

  • Pharmaceuticals
    • Vaccines
    • Specialty Pharmaceuticals
  • Biotechnology

Other Names/Subsidiaries

  • NovaMed Pharmaceuticals
  • SciClone Pharmaceuticals
See more in Biomedtracker

Latest on SciClone Pharmaceuticals (Holdings) Limited

Scrip

Asia Deal Watch: Daiichi Sankyo Teams With Nosis On Extrahepatic RNA Therapies

 
• By Joseph Haas, Jung Won Shin, and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Start-Up Nosis Partners Its AI Pl

Scrip

Asia Deal Watch: SciClone Obtains Commercial Rights In China To Menarini Breast Cancer Drug

 
• By Vibha Ravi, Jung Won Shin, Lisa Takagi, Dexter Jie Yan, and Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Menarini, SciClone Will Partner On

Scrip

Asia Deal Watch: Beximco Broadens Offerings, Capabilities With Sanofi Bangladesh Buy

 
• By Joseph Haas, Ian Haydock, Dexter Jie Yan, Jung Won Shin, and Anju Ghangurde

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sanofi Bangladesh Acquisition Adds To B

Scrip

Deal Watch: GSK Makes $85m Wager On Surface’s Preclinical NK Cell Therapy

 
• By Joseph Haas, Ian Haydock, and Jung Won Shin

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. GSK Becomes Surface Oncology’s Latest B